ClinicalTrials.gov
ClinicalTrials.gov Menu

Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00253565
Recruitment Status : Completed
First Posted : November 15, 2005
Last Update Posted : April 8, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Herbert Hurwitz, Duke University